Researchers at UT Southwestern Medical Center have discovered how a hormone interacts with a receptor on the surface of ...

In a significant advancement for prostate cancer research, a first-of-its-kind study led by Emory researchers uncovered how ...

Endocrine disruption during pregnancy and genetic drivers of bone disease were among the topics experts from UC San Francisco presented at the annual meeting of the Endocrine Society — ENDO 2025 — in ...

By understanding this newly revealed mechanism, scientists may now be able to design drugs that disable Hedgehog signaling at ...

XTANDI: the first and only androgen receptor inhibitor-based regimen to demonstrate overall survival benefit in non-metastatic hormone-sensitive prostate cancer (nmHSPC) with high-risk biochemical ...

A breakthrough in prostate cancer treatment is now available in Cincinnati, and it changed one patient's life faster than he ever imagined.

A new preclinical study from Weill Cornell Medicine reveals that linoleic acid, a type of omega-6 fatty acid commonly found in seed oils and animal products, can promote the growth of triple-negative ...

The lovable reality television star recently revealed his ongoing fight with prostate cancer and how he’s keeping his faith.

The results indicated that the BP associated with these targets were primarily related to the nuclear receptor-mediated steroid hormone signaling pathway, protein phosphorylation, and negative ...

Calcium/Calmodulin signaling pathway has been implicated to the initiation and progression of diverse human cancers. Loss or downregulation of Purkinje cell protein 4 (PCP4), is frequently observed in ...

Hormone therapy for metastatic prostate cancer can improve quality of life and longevity for those receiving treatment.

Hormone therapy for metastatic prostate cancer can improve quality of life and longevity for those receiving treatment.